TREM-like Transcript 2 is Stored in Human Neutrophil Primary Granules and is Up-regulated in Response to Inflammatory Mediators
Overview
Affiliations
The triggering receptor expressed on myeloid cell locus encodes a family of receptors that is emerging as an important class of molecules involved in modulating the innate immune response and inflammation. Of the 4 conserved members, including triggering receptor expressed on myeloid cells 1 and 2 and triggering receptor expressed on myeloid cell-like transcripts 1 and 2, relatively little is known about triggering receptor expressed on myeloid cell-like transcript 2 expression and function, particularly in humans. In this study, experiments were performed to determine if triggering receptor expressed on myeloid cell-like transcript 2 expression is conserved between mouse and human, demonstrating that human triggering receptor expressed on myeloid cell-like transcript 2 is expressed on cells of the lymphoid, as well as myeloid/granuloid lineages, similar to murine triggering receptor expressed on myeloid cell-like transcript 2. Consistent with studies in the mouse, triggering receptor expressed on myeloid cell-like transcript 2 expression is up-regulated in response to inflammatory mediators on human neutrophils. Importantly, it was shown that triggering receptor expressed on myeloid cell-like transcript 2, in resting human neutrophils, is predominantly localized to intracellular vesicles, including secretory vesicles and primary granules; with the majority of triggering receptor expressed on myeloid cell-like transcript 2 stored in primary granules. In contrast to other primary granule proteins, triggering receptor expressed on myeloid cell-like transcript 2 is not expelled on neutrophil extracellular traps but is retained in the plasma membrane following primary granule exocytosis. In summary, these findings establish that triggering receptor expressed on myeloid cell-like transcript 2 expression is conserved between species and is likely to be important in regulating neutrophil antimicrobial function following primary granule exocytosis.
Gayen S, Mukherjee S, Dasgupta S, Roy S Apoptosis. 2024; 29(11-12):1879-1913.
PMID: 39354213 DOI: 10.1007/s10495-024-02022-8.
Comprehensive analyses of circulating cardiometabolic proteins and objective measures of fat mass.
Titova O, Brunius C, Warensjo Lemming E, Stattin K, Baron J, Byberg L Int J Obes (Lond). 2023; 47(11):1043-1049.
PMID: 37550405 PMC: 10599989. DOI: 10.1038/s41366-023-01351-z.
The biology of TREM receptors.
Colonna M Nat Rev Immunol. 2023; 23(9):580-594.
PMID: 36750615 PMC: 9904274. DOI: 10.1038/s41577-023-00837-1.
Kuhn A, Frenzel S, Teumer A, Wittfeld K, Garvert L, Weihs A Int J Mol Sci. 2022; 23(22).
PMID: 36430248 PMC: 9692564. DOI: 10.3390/ijms232213764.
Immune checkpoint of B7-H3 in cancer: from immunology to clinical immunotherapy.
Zhao B, Li H, Xia Y, Wang Y, Wang Y, Shi Y J Hematol Oncol. 2022; 15(1):153.
PMID: 36284349 PMC: 9597993. DOI: 10.1186/s13045-022-01364-7.